Building upon these reviews [30,31,32], this article highlights the potential of utilizing Tf as a ligand, since these liposomes can specifically bind to and enter cancer cells, thereby improving drug accumulation within the tumor site while minimizing off-target effects. This evidence concerns the gene TF and cancer.